Adipose tissue, being  a source of chronic low-grade inflammation, activates cells of the immune system by producing cytokines and chemokines. The balance between pro- and anti-inflammatory molecules and their relationship with blood bacterial DNA in obese children and adolescents has not been studied sufficiently. This study aimed to find patterns of interaction between fractions of bacterial families in healthy and obese children, analyze cytokine levels and their relationship with blood bacterial DNA content, evaluate alpha diversity of blood microbiome and similarities of blood and fecal microbiomes. We examined 163 individuals (children and adolescents), who were divided into 2 groups, obese (n = 80, obesity classes I through III) and healthy (n = 83). The material sampled and studied was venous blood. Only individuals that have not been taking antibiotics, pro- and prebiotics for at least 3 months before the study were included. The methods employed were multiplex ELISA (enzyme immunoassay) and 16S rRNA gene sequencing (region V3–V4). From the angle of bacterial families, we found differences in their content (fractions) in blood microbiome and the frequency of isolation of their DNA therein. Nineteen  families accounted for over three quarters of all bacterial DNA identified in the blood. In obese children, one of the dominating roles was played by Ruminococcaceae, with their DNA a key part of the microbiome's alpha diversity, while in healthy participants this could be said about Bacteroidaceae. Analyzing beta diversity, we found that in obese children, fecal and blood microbiomes differed significantly, which indicates, mainly, extra-intestinal translocation of bacterial DNA. Obese children exhibited increased content of IL17A (p = 0.017) and PD-L1 (p = 0.021); there were differences in blood microbiome between groups. We identified the patterns of interaction between bacterial DNA fractions, and assessed cytokine levels.
VIEWS 1881
Progression assessment enables implementation of the colorectal cancer (CRC) tertiary prevention measures aimed at early detection and timely treatment of metastatic cancer. The study was aimed to develop a model of CRC progression using pathomorphological and molecular genetic characteristics of tumors. Relative expression of mRNAs of 63 genes from various functional groups was determined in the tumor specimens of 223 patients with stage T1–4N0–2M0 CRC. The median follow-up period was 42 months. Binary logistic regression models were constructed, in which likelihood of progression within 36 months after the CRC diagnosis was a target variable. Explanatory variables were as follows: tumor grade, angiolymphatic invasion, ratio of the number of metastatic lymph nodes to the total number of lymph nodes in the surgical specimen, patient’s age and tumor localization, as well as expression levels of genes CCNB1, Ki67, GRB7, IGF1, Il2, Il6, Il8, GATA3. Prediction accuracy of the model using clinical and morphological characteristics was 56.6%. Inclusion of CCNB1, Ki67, GRB7, IGF1, Il2, Il6, Il8, GATA3 expression profiles in the model increased accuracy to 80.6%. Thus, prediction of CRC progression for treatment personalization requires additional parameters beyond information acquired within the framework of conventional morphological TNM classification. The use of molecular markers as predictors significantly increases the CRC progression prediction accuracy. Further research is needed for validation and quality improvement of prognostic models.
VIEWS 2166
Theta-burst stimulation (TBS) is widely used due to induction of the long-lasting effects with short protocol duration. To reduce the variability of the effect, approaches to personalize it, such as using theta-gamma coupling frequencies (TGC), are being investigated. The study was aimed to develop the personalized protocol of navigated intermittent theta-burst stimulation (iTBS-ind) based on TGC, and to compare this protocol with the standard one (iTBS-5/50) and sham stimulation (iTBS-sham). The study involved 16 healthy volunteers (М — 7; 29.6 years), who were randomized to receive one session of each protocol of the left dorsolateral prefrontal cortex iTBS. The effects were estimated using the n-back test with simultaneous presentation of verbal and spatial stimuli (n = 2, 3), Digit Span test, Corsi blocks task, Tower of London test; testing was performed immediately before, immediately after and 60 min after stimulation. No severe adverse events were reported. Significant effect was obtained when performing assessment after 60 min for iTBS-5/50 in the n-back test with spatial stimuli (n = 3) (pcorr = 0.018), for all protocols in the Tower of London test (pcorr = 0.039 for iTBS-5/50, pcorr = 0.045 for iTBS-ind, pcorr = 0.003 for iTBS-sham). The iTBS-5/50 effect was significantly higher compared to iTBS-sham in the spatial n-back test (n = 3) (pcorr = 0.039), but lower compared to iTBS-ind and iTBS-sham in the Corsi blocks task (pcorr = 0.038 and 0.048, respectively). Thus, we failed to confirm the personalized protocol efficacy and superiority to the standard protocol and sham stimulation. Considering the effect of standard protocol, its further investigation can be promising.
VIEWS 1966
The regenerative medicine methods are being actively developed both in Russia and abroad due to relevance of this direction, especially in the field of the jaw osteoplasty. Autologous, allogeneic and xenoplastic materials, as well as the calcium phosphate ceramics synthetic preparations are conventionally used to normalize and stimulate osteogenesis, however, the treatment outcomes are not always unequivocal. The study was aimed to substantiate the use of the biocomplex consisting of plasma rich in growth factors (PRGF) and xenoplastic material to improve the jawbone osteogenesis efficacy. The study involved 136 patients (105 females and 31 males aged 21–67) divided into four groups based on the method of bone defect restoration. In group 1, no osteoplastic material was used; in group 2, osteoplasty involved the use of the PRGF fibrin gel; in group 3, the Osteobiol Gen-Os material was used; in group 4, osteoplasty involved using the combination of the Osteobiol Gen-Os material and plasma rich in growth factors (PRGF). Computed tomography and digital densitometry were performed before surgery and 3, 6, 12 months after it to assess the dynamics of osteogenesis. A year later restoration of the lost bone tissue volume was reported in 100% of patients in group 4, 70.27% of patients in group 3, 43.47% of patients in group 2, 37.5% of patients in group 1; Fisher's exact test revealed significant differences in the osteoplasty outcomes in groups 3 and 4 (p = 0.00002). There were significant differences in bone density between patients of groups 1 and 2 twelve months after surgery (p = 0.044), between patient of groups 3 and 4 three (p = 0.004), six (p = 0.0001) and 12 (p = 0.0001) months after surgery. The findings show that the method proposed is effective.
VIEWS 1815
Circulating monocytes are important actors of the tumor growth pathogenesis. It has been shown that some features of the monocyte populations expressing endocytosis receptors or the major histocompatibility complex components are observed in blood of patients with breast cancer. The study was aimed to assess the relationship of tumor parameters and blood cytokine profile with the composition of circulating monocyte populations in patients with localized and locally advanced breast cancer. The study has shown that the circulating monocytes’ phenotypic characteristics are correlated to the clinical and morphological features of the neoplastic process. The content of populations with the CD14+CD16++CD163+ and CD14++CD16+CD163+ phenotypes positively correlates with the disease stage, while larger primary tumor size is associated with lower CD14+CD16++ monocyte levels. Elevated serum levels of IL8 and МСР-1 are observed in breast cancer patients. High IL6 levels in patients with breast cancer are associated with the reduced percentage of CD14++CD16-HLA-DR+, CD14+CD16++HLA-DR+ and CD14++CD16-СD163+ monocytes. Thus, CD163+ and HLA-DR+ monocytes are associated with the clinical and morphological parameters and blood levels of cytokines, which suggests that these populations are involved in breast cancer progression and indicates that further research is advisable for translation of the findings into clinical practice.
VIEWS 1994